A.R.
Deibler,
J.
P.
(2008).
Arterial Spin-Labeling in Routine Clinical Practice,
Part 1: Technique and Artifacts.
AJNR Am J Neuroradiol,
Volume 29(7): 1228-34.
AIFA.
(2018,
febraio 12).
Agenzia Italiana Farmaco. Tratto da http://www.agenziafarmaco.gov.it: http://www.agenziafarmaco.gov.it/sites/default/files/NII_DHPC_Gadolinium
Alex M.
Wong,
F.-X.
Y.-L.
(2014).
Comparison of Three-Dimensional Pseudo-continuous Arterial Spin Labeling Perfusion Imaging With Gradient-Echo and Spin-Echo Dynamic Susceptibility Contrast MRI.
Journal of Magnetic Resonance Imaging,
39:427–433.
Bhaswati Roy,
R.
A.
(2013).
Comparative Evaluation of 3-Dimensional Pseudocontinuous Arterial Spin Labeling With Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Human Glioma.
J Comput Assist Tomogr,
Volume 37,
Number 3,.
Boyd AS,
Z.
J.
(2007).
Gadolinium deposition in nephtogenic fibrosing dermopathy.
J Am Acad Dermatol,
56: 27-30.
Carissa M.
White,
W.
B.
(2012).
Regional and Voxel-Wise Comparisons of Blood Flow Measurements Between Dynamic Susceptibility Contrast Magnetic Resonance Imaging (DSC-MRI) and Arterial Spin Labeling (ASL) in Brain Tumors.
J Neuroimaging,
1-7.
Carsten Warmuth,
M.
G.
(2003).
Quantification of Blood Flow in Brain Tumors: Comparison of Arterial Spin Labeling and Dynamic Susceptibility weighted MR Imaging.
Radiology,
532.
Combined Arterial Spin Label and Dynamic Susceptibility Contrast Measurement of Cerebral Blood Flow.
Magnetic Resonance in Medicine,
63:1548–1556.
H Cebeci,
O.
A.-I.
(2014).
Assesment of perfusion in glial tumors with arterial spin lebeling; comparison with dynamic susceptibility contrast method.
European Journal of Radiology,
Volume 83(10): 1914-9.
Hanna Järnum,
E.
G.-T.-C.-M.
(2010).
Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging.
Neuroradiology,
52:307–317.
Hong Ma,
Z.
W.
(2017).
Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery.
Experimental and therapeutic medicine,
13: 2691-2698.
Hua-Feng Xiao,
Z.-Y.
C.-L.-P.
(2015).
Astrocytic tumour grading: a comparative study.
Eur Radiol,
25:3423–3430.
J.-C.
Ferré,
E.
B.-N.-Y.
(2013).
Arterial spin labeling (ASL) perfusion: Tecniques and clinical use.
Diagn Intery Imaging,
Volume 94(12): 1211-1223.
Jingjing Jiang,
L.
Z.-Y.
(2014).
Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors.
Int J Clin Exp Pathol,
Volume 7(6): 2790–2799.
John A.
Detre,
H.
R.
(2012).
Applications of Arterial Spin Labeled MRI in the Brain.
Journal of Magnetic Resonance Imaging,
35:1026–1037.
L.
Kong,
H.
C.
(2016).
A meta-analysis of arterial spin labelling.
Clinical Radiology,
e1-e7.
M.
Grade,
J.
H.
(2015).
A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice.
Neuroradiology,
Volume 57: 1181-1202.
Mandy Kim Rau,
C.
B.
(2014).
Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas.
J Neurooncol,
120:557–566.
MF,
B.
(2006).
MR contrast agents,
the old and the new.
Europ J Radiol,
60: 314-323.
Qian Xu,
M.
Q.
(2017).
Tumor recurrence versus treatment effects in glioma comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Medicine,
96:50(e9332).
Ronald L.
Wolf,
D.
C.
(2003).
Susceptibility Contrast and Arterial Spin Labeled Perfusion MRI in Cerebrovascular Disease.
J Neuroimaging,
13:17-27.
Sven Haller,
G.
Z.-O.
(2016).
Arterial spin Labeling Perfusion of the Brain: Emerging Clinical Applications1.
Radiology,
Volume 281: 337-356.
Wang,
Z.
(2012).
Improving cerebral blood flow quantification for arterial spin labeled perfusion MRI by removing residual motion artifacts and global signal fluctuations.
Magnetic Resonance Imaging,
1409–1415.
Xu Q,
L.
Q.
(2017).
Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Medicine(Baltimore),
Volume 96(50): e9332.
Yuelei Lyu,
P.
S.
(2016).
Evaluation of Recurrent High-Grade Gliomas Treated With Bevacizumab: A Preliminary Report of 3D Pseudocontinuous Artery Spin Labeling.
J.
Magn.
Reson.
Imaging.